-Management to Provide 2014 Year-End Update and 2015 Outlook-
BOSTON--(BUSINESS WIRE)--Jan. 5, 2015--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer by the targeted killing of cancer stem cells,
today announced that the Company will host a conference call and slide
webcast on Thursday, January 8, 2015 at 4:30 p.m. Eastern Time to review
the company’s progress in 2014 and discuss upcoming milestones for 2015.
The call can be accessed by dialing (877) 341-5660 (U.S. and Canada) or
(315) 625-3226 (international), and entering passcode 60568979. To
access the live slide presentation, please use either the following
or visit the investors section of the Verastem website at www.verastem.com.
The teleconference replay will be available for one week by dialing
(855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international).
Replay Passcode 60568979 is required for playback. The webcast will also
be recorded and available for replay on the company’s website for 90
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to
treat cancer by the targeted killing of cancer stem cells. Cancer stem
cells are an underlying cause of tumor recurrence and metastasis.
Verastem is developing small molecule inhibitors of signaling pathways
that are critical to cancer stem cell survival and proliferation: FAK,
PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.
Source: Verastem, Inc.
Brian Sullivan, 781-292-4214